Exchange: "BioBill, Audit Opinion 'Disclaimer'... Cause for Delisting Occurs"
[Asia Economy Reporter Minji Lee] The Korea Exchange announced on the 30th that BioVille has triggered grounds for delisting.
The Exchange stated, "The company received a 'disclaimer of opinion' from the auditor on the 2019 fiscal year's financial statements due to scope limitation and uncertainty about the company's ability to continue as a going concern," adding, "We plan to review and resolve the matter by combining it with the delisting grounds from the 2018 fiscal year's audit opinion."
Hot Picks Today
!["Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]](https://cwcontent.asiae.co.kr/asiaresize/93/2025050713592847164_1746593968.jpg)
"Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
- Did Samsung and SK hynix Rise Too Much?... Foreign Assets Grow Despite Selling [Weekend Money]
- "Anyone Who Visited the Room Salon, Come Forward"… Gangnam Police Station Launches Full Staff Investigation After New Scandal
- "Drink Three Cups of Coffee and Stay Up All Night Before the Test"... Manual of Insurance Planner Who Collected 1 Billion Won in Payouts
- "Wearing a Leather Jacket in 30-Degree Heat, Jensen Huang Enjoys Street Food as Beijing's 'Mukbang Star': 'It's Delicious'"
Previously, the company also received a 'disclaimer of opinion' on the 2018 fiscal year's financial statements and was granted an improvement period until the 9th of next month. The company can file an objection by April 8.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
